Potential Target Receptors for the Pharmacotherapy of Burning Mouth Syndrome
<b>Objective:</b>Burning mouth syndrome (BMS) is a chronic, intractable orofacial pain condition characterized by a burning sensation in the oral mucosa without discernible lesions. The syndrome predominantly affects menopausal and postmenopausal women and is considered a form of nocipla...
Saved in:
Main Author: | Takahiko Nagamine |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/6/894 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Brain Networks in Burning Mouth Syndrome: A Narrative Review
by: Takahiko Nagamine
Published: (2025-07-01) -
Clinical features of epileptic syndrome and alteration of NMDAand of AMPA-receptors of glutamate in the pathogenesis of the disease in the patients with supratentorial meningiomas of the brain
by: V. N. Ochkolyas, et al.
Published: (2018-12-01) -
Low-dose aripiprazole for refractory burning mouth syndrome
by: Umezaki Y, et al.
Published: (2016-05-01) -
Psychometric Assessment of Clinical Factors in Burning Mouth Syndrome Progression
by: Ana Garcia-Martinez, et al.
Published: (2025-08-01) -
Stratification of Patients with Burning Mouth Syndrome in the Croatian Population: A Single-Center Cross-Sectional Study
by: Ana Glavina, et al.
Published: (2025-04-01)